Lexicon Pharmaceuticals (LXRX) Return on Invested Capital (2011)

Lexicon Pharmaceuticals' (LXRX) quarterly Return on Invested Capital came in at 0.28% in Q4 2011.

Lexicon Pharmaceuticals (LXRX) Return on Invested Capital (2011) Analysis & Trends

Lexicon Pharmaceuticals (LXRX) has 1 years of Return on Invested Capital data on file, last reported at 0.28% in Q4 2011.

On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.28% in Q4 2011; TTM through Dec 2011 was 0.28%, a N/A change from a year earlier, with the FY2014 full-year figure at 0.09%, changed N/A from the prior year.
Return on Invested Capital for Q4 2011 stood at 0.28%.
Over the last five years, Return on Invested Capital for LXRX reached as high as 0.28% in Q4 2011 and fell as low as 0.28% in Q4 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.04%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Lexicon Pharmaceuticals	979.13 Mn	808.47 Mn	20.99 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2011	-0.28%